Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn - A single-center, 5-year experience

Anju Gupta, Shantanu Rastogi, Rakesh Sahni, Alok Bhutada, David Bateman, Deepa Rastogi, Arthur Smerling, Jen Tien Wung

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective. To evaluate the effect of inhaled nitric oxide (INO) in pulmonary hypertension of the newborn (PH) in a single center over 5 years using gentle ventilation (GV), without hyperventilation or induced alkalosis. Methods: Data from 229 consecutive infants with PH of varied etiology treated with INO and GV, and from 67 infants with meconium aspiration syndrome (MAS) and primary PH (PPHN) treated with GV alone were reviewed over a 5-year period (86% outborn). INO was initiated at 25 ppm when PH and severe hypoxemia persisted despite maximal optimal ventilation. Hyper-ventilation or systemic alkalosis were not attempted. Results: Mean duration of ventilation was 9.9 ± 14 days (median 6.5 days). Average mean airway pressure (MAP) dropped from 17.7 ± 4.3 cm H2O at the referral hospital to 13.2 ± 2.5 cm H2O (p < 0.001) following admission to our unit using conventional settings and GV, before starting INO. Mean oxygenation index (OI) dropped from 46.8 ± 24.5 to 22.7 ± 21.4 within 24 hours of INO therapy (p < 0.001). Infants with higher baseline pH and lower baseline OI responded better to INO (p < 0.02). Overall survival was 72%. Patients with MAS and PPHN had the best response, 92% survived and there was a 46% reduction in need for extracorporeal membrane oxygenation (ECMO) compared to historical pre-INO period controls (23.9% vs. 12.8%, p < 0.01). In the infants treated with GV alone, the MAP dropped from 17.2 ± 4.3 cm H2O at the referral hospital to 12.6 ± 2.4 after GV was started in our unit. Conclusions: We conclude that INO is an effective and well-tolerated therapy for PH in infants receiving GV.

Original languageEnglish (US)
Pages (from-to)435-441
Number of pages7
JournalJournal of Perinatology
Volume22
Issue number6
DOIs
StatePublished - Sep 2002
Externally publishedYes

Fingerprint

Pulmonary Hypertension
Ventilation
Nitric Oxide
Newborn Infant
Meconium Aspiration Syndrome
Therapeutics
Alkalosis
Referral and Consultation
Pressure
Extracorporeal Membrane Oxygenation
Hyperventilation
Survival

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn - A single-center, 5-year experience. / Gupta, Anju; Rastogi, Shantanu; Sahni, Rakesh; Bhutada, Alok; Bateman, David; Rastogi, Deepa; Smerling, Arthur; Wung, Jen Tien.

In: Journal of Perinatology, Vol. 22, No. 6, 09.2002, p. 435-441.

Research output: Contribution to journalArticle

Gupta, Anju ; Rastogi, Shantanu ; Sahni, Rakesh ; Bhutada, Alok ; Bateman, David ; Rastogi, Deepa ; Smerling, Arthur ; Wung, Jen Tien. / Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn - A single-center, 5-year experience. In: Journal of Perinatology. 2002 ; Vol. 22, No. 6. pp. 435-441.
@article{579991ed8234444f8e97732fe03eff3d,
title = "Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn - A single-center, 5-year experience",
abstract = "Objective. To evaluate the effect of inhaled nitric oxide (INO) in pulmonary hypertension of the newborn (PH) in a single center over 5 years using gentle ventilation (GV), without hyperventilation or induced alkalosis. Methods: Data from 229 consecutive infants with PH of varied etiology treated with INO and GV, and from 67 infants with meconium aspiration syndrome (MAS) and primary PH (PPHN) treated with GV alone were reviewed over a 5-year period (86{\%} outborn). INO was initiated at 25 ppm when PH and severe hypoxemia persisted despite maximal optimal ventilation. Hyper-ventilation or systemic alkalosis were not attempted. Results: Mean duration of ventilation was 9.9 ± 14 days (median 6.5 days). Average mean airway pressure (MAP) dropped from 17.7 ± 4.3 cm H2O at the referral hospital to 13.2 ± 2.5 cm H2O (p < 0.001) following admission to our unit using conventional settings and GV, before starting INO. Mean oxygenation index (OI) dropped from 46.8 ± 24.5 to 22.7 ± 21.4 within 24 hours of INO therapy (p < 0.001). Infants with higher baseline pH and lower baseline OI responded better to INO (p < 0.02). Overall survival was 72{\%}. Patients with MAS and PPHN had the best response, 92{\%} survived and there was a 46{\%} reduction in need for extracorporeal membrane oxygenation (ECMO) compared to historical pre-INO period controls (23.9{\%} vs. 12.8{\%}, p < 0.01). In the infants treated with GV alone, the MAP dropped from 17.2 ± 4.3 cm H2O at the referral hospital to 12.6 ± 2.4 after GV was started in our unit. Conclusions: We conclude that INO is an effective and well-tolerated therapy for PH in infants receiving GV.",
author = "Anju Gupta and Shantanu Rastogi and Rakesh Sahni and Alok Bhutada and David Bateman and Deepa Rastogi and Arthur Smerling and Wung, {Jen Tien}",
year = "2002",
month = "9",
doi = "10.1038/sj.jp.7210761",
language = "English (US)",
volume = "22",
pages = "435--441",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn - A single-center, 5-year experience

AU - Gupta, Anju

AU - Rastogi, Shantanu

AU - Sahni, Rakesh

AU - Bhutada, Alok

AU - Bateman, David

AU - Rastogi, Deepa

AU - Smerling, Arthur

AU - Wung, Jen Tien

PY - 2002/9

Y1 - 2002/9

N2 - Objective. To evaluate the effect of inhaled nitric oxide (INO) in pulmonary hypertension of the newborn (PH) in a single center over 5 years using gentle ventilation (GV), without hyperventilation or induced alkalosis. Methods: Data from 229 consecutive infants with PH of varied etiology treated with INO and GV, and from 67 infants with meconium aspiration syndrome (MAS) and primary PH (PPHN) treated with GV alone were reviewed over a 5-year period (86% outborn). INO was initiated at 25 ppm when PH and severe hypoxemia persisted despite maximal optimal ventilation. Hyper-ventilation or systemic alkalosis were not attempted. Results: Mean duration of ventilation was 9.9 ± 14 days (median 6.5 days). Average mean airway pressure (MAP) dropped from 17.7 ± 4.3 cm H2O at the referral hospital to 13.2 ± 2.5 cm H2O (p < 0.001) following admission to our unit using conventional settings and GV, before starting INO. Mean oxygenation index (OI) dropped from 46.8 ± 24.5 to 22.7 ± 21.4 within 24 hours of INO therapy (p < 0.001). Infants with higher baseline pH and lower baseline OI responded better to INO (p < 0.02). Overall survival was 72%. Patients with MAS and PPHN had the best response, 92% survived and there was a 46% reduction in need for extracorporeal membrane oxygenation (ECMO) compared to historical pre-INO period controls (23.9% vs. 12.8%, p < 0.01). In the infants treated with GV alone, the MAP dropped from 17.2 ± 4.3 cm H2O at the referral hospital to 12.6 ± 2.4 after GV was started in our unit. Conclusions: We conclude that INO is an effective and well-tolerated therapy for PH in infants receiving GV.

AB - Objective. To evaluate the effect of inhaled nitric oxide (INO) in pulmonary hypertension of the newborn (PH) in a single center over 5 years using gentle ventilation (GV), without hyperventilation or induced alkalosis. Methods: Data from 229 consecutive infants with PH of varied etiology treated with INO and GV, and from 67 infants with meconium aspiration syndrome (MAS) and primary PH (PPHN) treated with GV alone were reviewed over a 5-year period (86% outborn). INO was initiated at 25 ppm when PH and severe hypoxemia persisted despite maximal optimal ventilation. Hyper-ventilation or systemic alkalosis were not attempted. Results: Mean duration of ventilation was 9.9 ± 14 days (median 6.5 days). Average mean airway pressure (MAP) dropped from 17.7 ± 4.3 cm H2O at the referral hospital to 13.2 ± 2.5 cm H2O (p < 0.001) following admission to our unit using conventional settings and GV, before starting INO. Mean oxygenation index (OI) dropped from 46.8 ± 24.5 to 22.7 ± 21.4 within 24 hours of INO therapy (p < 0.001). Infants with higher baseline pH and lower baseline OI responded better to INO (p < 0.02). Overall survival was 72%. Patients with MAS and PPHN had the best response, 92% survived and there was a 46% reduction in need for extracorporeal membrane oxygenation (ECMO) compared to historical pre-INO period controls (23.9% vs. 12.8%, p < 0.01). In the infants treated with GV alone, the MAP dropped from 17.2 ± 4.3 cm H2O at the referral hospital to 12.6 ± 2.4 after GV was started in our unit. Conclusions: We conclude that INO is an effective and well-tolerated therapy for PH in infants receiving GV.

UR - http://www.scopus.com/inward/record.url?scp=0036708232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036708232&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7210761

DO - 10.1038/sj.jp.7210761

M3 - Article

VL - 22

SP - 435

EP - 441

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 6

ER -